GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins December 18, 2024
Displaying entries 38051 - 38100 of 40384 in total
PDB ID UniProt ID ▼ Title Descriptor
5WDU 5WDU HIV-1 Env BG505 SOSIP.664 H72C-H564C trimer in complex with bNAbs PGT122 Fab, 35O22 Fab and NIH45-46 scFv
5WB9 5WB9 Crystal structure of CD4 binding site antibody N60P23 in complex with HIV-1 clade A/E strain 93TH057 gp120 core
5WAV 5WAV Fc AbVance: Increasing our knowledge of antibody structural space to enable faster and better decision-making in antibody drug discovery.
5WAV 5WAV Fc AbVance: Increasing our knowledge of antibody structural space to enable faster and better decision-making in antibody drug discovery.
5W9I 5W9I MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4 Spike glycoprotein, G4 VH, G4 VL
5W9H 5W9H MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4
5W6U 5W6U Crystal structure of the A/Puerto Rico/8/1934 (H1N1) influenza virus hemagglutinin in complex with cyclic peptide CP121068 (P2)
5W6T 5W6T Crystal structure of the A/Puerto Rico/8/1934 (H1N1) influenza virus hemagglutinin in complex with cyclic peptide CP151070 (P7)
5W6R 5W6R Crystal structure of the A/Puerto Rico/8/1934 (H1N1) influenza virus hemagglutinin in complex with cyclic peptide CP141099 (P6)
5W6I 5W6I Crystal structure of the A/Puerto Rico/8/1934 (H1N1) influenza virus hemagglutinin in complex with cyclic peptide CP141046 (P3)
5W6G 5W6G Human antibody 6649 in complex with influenza hemagglutinin H1 Solomon Islands
5W6G 5W6G Human antibody 6649 in complex with influenza hemagglutinin H1 Solomon Islands
5W6D 5W6D Crystal structure of BG505-SOSIP.v4.1-GT1-N137A in complex with Fabs 35022 and 9H/109L
5W5U 5W5U Crystal structure of the A/Puerto Rico/8/1934 (H1N1) influenza virus hemagglutinin in complex with cyclic peptide CP141037 (P4)
5W5S 5W5S Crystal structure of the A/Puerto Rico/8/1934 (H1N1) influenza virus hemagglutinin in complex with cyclic peptide CP141019 (P5)
5W4L 5W4L Crystal structure of the non-neutralizing and ADCC-potent C11-like antibody N12-i3 in complex with HIV-1 clade A/E gp120, the CD4 mimetic M48U1, and the antibody N5-i5.
5W42 5W42 Crystal structure of human monoclonal antibody H3v-47 in complex with influenza virus hemagglutinin from A/Minnesota/11/2010 (H3N2)
5W42 5W42 Crystal structure of human monoclonal antibody H3v-47 in complex with influenza virus hemagglutinin from A/Minnesota/11/2010 (H3N2)
5W1M 5W1M MACV GP1 CR1-07 Fab complex
5W1M 5W1M MACV GP1 CR1-07 Fab complex
5W1K 5W1K JUNV GP1 CR1-10 Fab CR1-28 Fab complex
5W1K 5W1K JUNV GP1 CR1-10 Fab CR1-28 Fab complex
5W0D 5W0D Inferred precursor (UCA) of the human antibody lineage K03.12 in complex with influenza hemagglutinin H1 Solomon Islands/03/2006
5W0D 5W0D Inferred precursor (UCA) of the human antibody lineage K03.12 in complex with influenza hemagglutinin H1 Solomon Islands/03/2006
5W08 5W08 A/Texas/50/2012(H3N2) Influenza hemagglutinin in complex with K03.12 Fab
5W08 5W08 A/Texas/50/2012(H3N2) Influenza hemagglutinin in complex with K03.12 Fab
5VVX 5VVX Structural Investigations of the Substrate Specificity of Human O-GlcNAcase
5VVV 5VVV Structural Investigations of the Substrate Specificity of Human O-GlcNAcase
5VVU 5VVU Structural Investigations of the Substrate Specificity of Human O-GlcNAcase
5VVT 5VVT Structural Investigations of the Substrate Specificity of Human O-GlcNAcase
5VTA 5VTA Co-Crystal Structure of DPPIV with a Chemibody Inhibitor
5VQE 5VQE Beta-glucoside phosphorylase BglX bound to 2FGlc
5VPL 5VPL CRYSTAL STRUCTURE OF DER F 1 COMPLEXED WITH FAB 4C1
5VPG 5VPG CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1
5VOD 5VOD Crystal structure of HCMV Pentamer in complex with neutralizing antibody 9I6
5VOD 5VOD Crystal structure of HCMV Pentamer in complex with neutralizing antibody 9I6
5VOC 5VOC Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD
5VOC 5VOC Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD
5VOB 5VOB Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21
5VOB 5VOB Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21
5VN8 5VN8 Cryo-EM model of B41 SOSIP.664 in complex with fragment antigen binding variable domain of b12 Envelope glycoprotein gp160, b12 Fab heavy chain, b12 Fab light chain
5VN3 5VN3 Cryo-EM model of B41 SOSIP.664 in complex with soluble CD4 (D1-D2) and fragment antigen binding variable domain of 17b 17b Fab light chain, Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab heavy chain
5VLI 5VLI Computationally designed inhibitor peptide HB1.6928.2.3 in complex with influenza hemagglutinin (A/PuertoRico/8/1934)
5VL3 5VL3 CD22 d1-d3 in complex with therapeutic Fab Epratuzumab
5VL3 5VL3 CD22 d1-d3 in complex with therapeutic Fab Epratuzumab
5VK2 5VK2 Structural basis for antibody-mediated neutralization of Lassa virus
5VIY 5VIY BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195
5VIY 5VIY BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195
5VIF 5VIF Electrophilic probes for deciphering substrate recognition by O-GlcNAc transferase
5VIE 5VIE Electrophilic probes for deciphering substrate recognition by O-GlcNAc transferase

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024